Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial

Psychosomatic Medicine

Volumn 59, Issue 3, 1997, Pages 241-250

  Lustman, Patrick J ^a,b   Griffith, Linda S ^a   Clouse, Ray E ^a   Freedland, Kenneth E ^a   Eisen, Seth A ^a,b   Rubin, Eugene H ^a   Carney, Robert M ^a   Mcgill, Janet B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antidepressive agents; Blood glucose; Depressive disorder; Diabetes mellitus

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; NORTRIPTYLINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030938705     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199705000-00007     Document Type: Article

References (63)

1. Robins LN, Regier DA: Psychiatric disorders in America: The Epidemiologic Catchment Area Study. New York, The Free Press, Macmillan, Inc. 1991
2. Gavard JA, Lustman PJ, Clouse RE: Prevalence of depression in adults with diabetes: An epidemiological evaluation. Diabetes Care 16:1167-1178, 1993
3. Lustman PJ, Velozo CA, Eubanks B, et al.: Effects of psychiatric disorder on rehabilitation efforts and ability to return to work following a job-related injury. Work 1:37-43, 1991
4. Styron W: Darkness Visible: A Memoir of Madness. New York, Random House, 1990
5. Wells KB, Stuart A, Hays RD, et al.: The functioning and well-being of depressed patients: Results from the medical outcomes study. JAMA 262:914-919, 1989
6. Lustman PJ, Griffith LS, Clouse RE, et al.: Psychiatric illness in diabetes: Relationship to symptoms and glucose control. J Nerv Ment Dis 174:736-742, 1986
7. Lustman PJ, Griffith LS, Clouse RE: Depression in adults with diabetes: Results of a 5-year follow-up study. Diabetes Care 11:605-612, 1988
8. Friis R, Nanjundappa G: Diabetes, depression and employment status. Soc Sci Med 23:471-475, 1986
9. Mazze RS, Lucido D, Shamoon H: Psychological and social correlates of glycemic control. Diabetes Care 7:360-366, 1984
10. deGroot M, Jacobson AM, Samson JA: Psychiatric illness in patients with type I and type II diabetes mellitus. Psychosom Med 56:176A, 1994
11. Lustman PJ, Griffith LS, Gavard JA, et al.: Depression in adults with diabetes. Diabetes Care 15:1631-1639, 1992
12. Littlefield CH, Craven JL, Rodin GM, et al.: Relationship of self-efficacy and bingeing to adherence to diabetes regimen among adolescents. Diabetes Care 15:90-94, 1992
13. McGill JB, Lustman PJ, Griffith LS, et al.: Relationship of depression to compliance with self-monitoring of blood glucose. Diabetes 41:A84, 1992
14. Trivedi M, Rush AJ: A review of randomized controlled medication trials in major depression. Biol Psychiatry 31: 188-189A, 1992
15. Frank E, Karp JF, Rush AJ: Efficacy of treatments for major depression. Psychopharmacol Bull 29:457-475, 1993
16. Fakhri O, Fadhli AA, el Rawi RM: Effect of electroconvulsive therapy on diabetes mellitus. Lancet 2:775-777, 1980
17. Normand PS, Jenike MA: Lowered insulin requirements after ECT. Psychosomatics 25:418-419, 1984
18. Kaplan SM, Mass JW, Pixley JM, et al.: Use of imipramine in diabetics: Effects on glycosuria and blood sugar levels. JAMA 174:511-517, 1960
19. True BL, Perry PJ, Burns EA: Profound hypoglycemia with addition of a tricyclic antidepressant to maintenance sulfonylurea therapy. Am J Psychiatry 144:1220-1221, 1987
20. Saran AS: Antidiabetic effects of lithium. J Clin Psychiatry 43:383-384, 1987
21. Cooper AJ: The action of mebanazine, a monoamine oxidase inhibitor antidepressant drug in diabetes. II. Int J Neuropsychiatry 2:342-345, 1966
22. Lustman PJ, Griffith LS, Clouse RE, et al.: Effects of alprazolam on glucose regulation in adult diabetic patients: Results of a double-blind, placebo-controlled trial. Diabetes Care 18:1133-1139, 1995
23. Robins LN, Heizer JE, Cottler LB, et al.: The Diagnostic Interview Schedule-Version III-R. St. Louis, MO, Washington University, 1989
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC, American Psychiatric Association, 1987
25. Robins LN, Heizer JE, Croughan J: The NIMH Diagnostic Interview Schedule: Version III. Public Health Service (Hss) ADM-T-42-3 (5-81,8-81), Washington, DC, 1981
26. Lustman PJ, Harper GW, Griffith LS, et al.: Use of the Diagnostic Interview Schedule in patients with diabetes. J Nerv Ment Dis 174:743-746, 1986
27. Lustman PJ, Freedland KE, Carney RM, et al.: Similarity of depression in diabetic and psychiatric patients. Psychosom Med 54:602-611, 1992
28. Beck AT, Beamesderfer A: Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 7:151-169, 1974
29. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 8:77-100, 1988
30. Goldstein DE, Little RR, Wiedmeyer H, et al.: Glycated hemoglobin: Methodologies and clinical applications. Clin Chem 32:B64-B70, 1986
31. 1c levels in a diabetes detection program. J Clin Endocrinol Metab 47:578-580, 1978
32. Kilzer P: Glycated hemoglobin and diabetes. Clin Chem 31:1060-1067, 1985
33. Eisen SA, Hanpeter JA, Kreuger LW, et al.: Monitoring medication compliance: Description of a new device. J Compliance Health Care 2:131-142, 1987
34. Eisen SA, Miller DK, Woodward RS, et al.: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150:1881-1884, 1990
35. Eisen SA, Woodward RS, Miller D, et al.: Effect of medication compliance on the control of hypertension. J Gen Intern Med 2:298-305, 1987
36. Preskorn SH, Burke MJ, Fast GA: Therapeutic drug monitoring: Principles and practice. Psychiatr Clin North Am 16:611-645, 1993
37. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, Second Edition. Hillsdale, NJ, Lawrence Erlbaum, 1983
38. Loehlin JC: Latent Variable Models: an Introduction to Factor, Path, and Structural Analysis. Hillsdale, NJ, Lawrence Erlbaum, 1987
39. Carney RM, Rich MW, Freedland KE, et al.: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627-633, 1988
40. Ahern KD, Gorkin L, Anderson JL, et al., for the CAPS Investigators: Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 66:59-62, 1990
41. Anda R, Williamson D, Jones D, et al.: Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4:285-294, 1993
42. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: Impact on 6-month survival. JAMA 270:1819-1825, 1993
43. Ladwig KH, Kiesser M, Donig J, et al.: Affective disorders and survival after acute myocardial infarction. Eur Heart J 12:959-964, 1991
44. Kennedy GJ, Hofer MA, Cohen D, et al.: Significance of depression and cognitive impairment in patients undergoing programmed stimulation of cardiac arrythmias. Psychosom Med 49:410-421, 1987
45. Lloyd CE, Matthews KA, Wing RR, et al.: Psychosocial factors and complications of IDDM: The Pittsburgh Epidemiology of Diabetes Complications: Study VIII. Diabetes Care 15:166-172, 1992
46. Robinson N, Fuller H, Edmeades SP: Depression and diabetes. Diabetic Med 5:268-274, 1988
47. Carney RM, Freedland KE, Lustman PJ, et al.: Depression and coronary disease in diabetic patients: A 10-year follow-up. Psychosom Med 56:149, 1994
48. Smith GR Jr, Monson RA, Ray DC: Psychiatric consultation in somatization disorder: A randomized controlled study. N Engl J Med 314:1407-1413, 1986
49. Mumford E, Schlesinger HJ, Glass GV: A critical review and indexed bibliography of the literature up to 1978 on the effects of psychotherapy on medical utilization: Report to NIMH [abstract]. National Institutes of Mental Health, Rockville, MD Contract-MH-77-0049:1978
50. Fawzy FI, Fawzy NW, Hyun CS, et al.: Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681-689, 1993
51. Spiegel D, Bloom JR, Kraemer HC, et al.: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989
52. Frasure-Smith N, Prince R: The ischemic heart disease life stress monitoring program: Impact on mortality. Psychosom Med 47:431-445, 1985
53. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589-596, 1987
54. Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 243:1147-1150, 1980
55. Depression Guideline Panel: Depression in primary care. Vol. 5. Detection, Diagnosis and Treatment [abstract]. Department of Health and Human Services, Rockville, MD, AHCPR No. 93:0550:1993
56. DCCT, The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-985, 1993
57. Morisake N, Watanabe S, Kobayashi J, et al.: Diabetic control and progression of retinopathy in elderly patients: Five-year follow-up study. J Am Geriatr Soc 42:142-145, 1994
58. Lustman PJ: Anxiety disorders in adults with diabetes mellitus. Psychiatr Clin North Am 11:419-432, 1988
59. Finestone DH, Weiner RD: Effects of ECT on diabetes mellitus: An attempt to account for conflicting data. Acta Psychiatr Scand 70:321-326, 1984
60. Gupta B, Awasthi A, Jaju BR: Effect of acute and chronic imipramine treatment on glucose homeostasis. Indian J Med Res 96:65-71, 1992
61. Kathol RG, Jaeckle R, Wysham C, Sherman BM: Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia. Psychiatry Res 41:45-52, 1992
62. Potter van Loon BJ, Radder JK, Frolich M, et al.: Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes 16: 79-85, 1992
63. Gray DS, Fujioka K, Devine W, et al.: Fluoxetine treatment of the obese diabetic. Int J Obes 16:193-198, 1992